RESEARCHERS are to investigate why far fewer women opt to take part in screening programmes for bowel cancer than for breast or cervical cancer.
Bowel cancer is the UK’s second-biggest cancer killer, accounting for 10 per cent of all cancer deaths, yet only just over half of women eligible for the screening programme in Scotland take part.
“Study will look at various factors that might be barriers”Dr Katie Robb
The 58 per cent uptake rate for bowel screening among women contrasts with participation rates of 74 per cent and 71 per cent for breast and cervical screening respectively.
Now researchers at Glasgow University’s Institute of Health and Wellbeing have won an £84,000 grant from the National Awareness and Early Diagnosis Initiative to try to improve participation rates.
Dr Katie Robb, who is leading the project with Professor Colin McCowan of the Robertson Centre for Biostatistics, said: “We know that screening is an effective way to detect cancer early in its development before symptoms may have appeared, and catching it at an earlier stage can significantly reduce deaths.
“Public support for screening programmes is high, with surveys in the US and the UK showing 90 per cent of people in favour, but actual uptake of screening opportunities varies dramatically.
“It is important to understand why bowel cancer screening is failing to achieve the same uptake rates as breast or cervical screening.”
Bowel cancer screening is a much more recent addition to the cancer screening programmes in Scotland, having been introduced in 2007 for anyone aged 50 to 74, while breast and cervical screening both began in 1988. However, participation rates for the latter achieved participation rates of more than 70 per cent within a few years.
Bowel cancer screening comprises a home-testing kit. The test involves wiping small samples of faeces on a piece of card which is then put in a hygienically sealed envelope and sent to a lab for testing. The sample is checked for traces of blood that might indicate a cancerous state in the bowel.
Dr Robb said: “Bowel cancer screening is a test you do yourself at home and so people may be slightly less familiar with this approach.
“Our study will look at the various factors – socio-economic, demographic, or relating to medical differences – that might be barriers to participation and consider new ways of encouraging people to take the opportunity to consider benefiting from a potentially life-saving intervention.”
Dr Jodie Moffat, head of early diagnosis at Cancer Research UK, said: “There are plans to introduce a new, easier-to-use bowel screening test across Scotland within the next few years, and that, together with what we learn from this study, could help encourage more people to take part.”
The researchers will use data on screening invitations and uptake from the NHS Health Scotland’s Screening Programmes for women in the Greater Glasgow and Clyde Health Board region to explore differences in uptake for bowel versus breast and cervical screening services.